![Gordon Parry](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Gordon Parry
Nessuna posizione attualmente
Profilo
Gordon Parry is Vice President-Research & Development of Monogram Biosciences, Inc., which he joined in 2007 as Senior Director of Research and Development.
Prior to joining Monogram, he worked for twelve years at Berlex Biosciences, where he was the Department Head of Cancer Research Department.
Previously, Mr. Parry held a variety of research positions in academia, including ten years at the University of California's Lawrence Berkeley Laboratory.
Currently, he is an Advisory Council Member for the California Breast Cancer Research Program.
Precedenti posizioni note di Gordon Parry
Società | Posizione | Fine |
---|---|---|
Monogram Biosciences, Inc.
![]() Monogram Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Monogram Biosciences, Inc. develops and commercializes diagnostic products for the treatment of human immunodeficiency virus (HIV) infection, hepatitis C virus (HCV) infection, and other viral illnesses, as well as cancer and other diseases. It offers HIV tests, including genotypic, phenotypic, tropism, and combined phenotype and genotype assays, suppression management and viral load testing, HCV assays and oncology tests. The company was founded in 1995 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
Formazione di Gordon Parry
University of London | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
Monogram Biosciences, Inc.
![]() Monogram Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Monogram Biosciences, Inc. develops and commercializes diagnostic products for the treatment of human immunodeficiency virus (HIV) infection, hepatitis C virus (HCV) infection, and other viral illnesses, as well as cancer and other diseases. It offers HIV tests, including genotypic, phenotypic, tropism, and combined phenotype and genotype assays, suppression management and viral load testing, HCV assays and oncology tests. The company was founded in 1995 and is headquartered in South San Francisco, CA. | Commercial Services |
- Borsa valori
- Insiders
- Gordon Parry